Uncertainty over Serum vaccine supply to Bangladesh grows
Govt yet to receive 50 lakh doses from Serum scheduled for March
Manzur H Maswood | Published: 23:30, Apr 01,2021 | Updated: 23:55, Apr 01,2021
Uncertainty over the COVID-19 vaccine supply to Bangladesh by Serum Institute of India has increased as the Indian manufacturer failed to supply the committed 50 lakh doses of the Oxford-AstraZeneca-developed vaccine in March.
Serum has also kept Bangladesh authorities in dark about when and how many doses of the vaccine it will send in the next consignment although the country has a shortage of vaccine doses to continue its vaccination programme, including the beginning of the second dose administration on April 8.